|
Frontier
Forum of Drug Discovery in Post-Genome Era |
|
Dalian
. China |
|
Oct.18,
2003 |
|
|
|
Speakers |
|
|
|
|
|
|
 |
|
Professor
Peter J. Hunter, Ph.D. (Keynote Speaker)
Member of Royal Society of New Zealand
|
|
|
Title:
Physiome Project |
|
|
|
|
|
|
|
|
|
|
|
 |
|
Xiaodong
Wang, Ph.D. (Keynote
Speaker)
Professor of Biochemistry,
Southwestern Medical Center at
University of Texas at Dallas, USA
|
|
|
|
Title:
Apoptotic Pathways and Their Potential Pharmaceutical Applications |
|
|
|
|
|
|
|
 |
|
Yuan Xu,
Ph.D.,
Head of Worldwide Pharmaceutical Development, GlaxoSmithKline |
|
|
|
Title:
Biopharmaceutical Development Strategy: a CMC perspective |
|
|
|
|
|
|
|
 |
|
Yifan
Dai, Ph.D.,
Senior Scientist, Revivicor Inc. |
|
|
|
Title:
Cloning of Genetic Modified Pigs for Xenotransplantation |
|
|
|
|
|
|
|
 |
|
|
|
|
Xinhe Bao,Ph.D.
Session Chair of Frontier Forum
President, Dalian Institute of Chemical Physics,
Chinese Academy of Sciences |
|
More
than 500 people participated in the Frontier Forum of Drug Discovery
in Post-Genome Era |
|
|
|
|
|
|
|
 |
|
|
|
|
Dr. Xiaodan Mei present
WHTS Honorary Member Plaque to Dr.Peter Hunter |
|
Dr. Xiaodan Mei present
WHTS Honorary Member Plaque to Dr.Xinhe Bao |
|
|
|
|
|
|